Executive Summary In this article, we cover the hidden part of the iceberg of peer review studies, which is the surprisingly low percentage of these studies that can be replicated. Introduction The problems in replicating peer-reviewed research, even when published in the most prestigious journals, are a massive and understated problem with peer-reviewed studies. Wait…
Executive Summary The pharmaceutical industry employs a variety of underhanded tactics to significantly extend the patent protection for its drugs. Introduction This article describes the many ways in which pharmaceutical companies unethically extend drug patents and how the FDA looks the other way. Wait One Second… Why is The Article Not Viewable? You are seeing…
Executive Summary  Me too drugs or copy drugs are a form of fake innovation by pharmaceutical companies. Introduction The majority of drugs that are approved are not innovative and are referred to as copycat drugs or me too drugs. Wait One Second… Why is The Article Not Viewable? You are seeing this text instead of…
Executive Summary The current drug development system in the U.S. could easily be replaced by a far more efficient and higher quality system that removes the drug companies. Introduction One of the tricks drug companies use to market new drugs is to claim that their new drug has fewer and less severe side effects than…
Executive Summary Peer review journals are typically held up as the gold standard of research, while having many problems that tend to be overlooked. Introduction When some readers have a serious disagreement with an article at Brightwork Research & Analysis, the opposing individual, who is often offended, will state that the articles at Brightwork are…
Executive Summary The vaccine manufacturers used a trick after receiving their EUA from the FDA. They unblinded the studies, which ruined them for long-term study. Introduction Clinical trials are supposed to be blinded. However, after receiving the Emergency Use Authorization, the drug companies unblinded the study, which prevented the study from validating longer term (greater…
Executive Summary Ethical considerations are used as an excuse for pharmaceutical companies to end clinical trials early. This is done to hide the adverse effects of the drug. Introduction We have observed a pattern when hearing that a study must end early because the. Wait One Second… Why is The Article Not Viewable? You are…
Executive Summary The vast majority of studies paid for by pharmaceutical companies are rigged to result in overly positive outcomes. Introduction Clinical trials are normally and increasingly paid for by pharmaceutical companies. Pharmaceutical companies have little interest in science and rig the clinical trial to achieve the desired outcome. In this process, the FDA is…
Executive Summary This article covers why unpublished studies are essential to review when determining the effectiveness of any treatment. Introduction There is a bias in the publication of scientific studies. This is why it is important also to review unpublished studies. Wait One Second… Why is The Article Not Viewable? You are seeing this text…
Wait One Second… Why is The Article Not Viewable? You are seeing this text instead of the article because of two potential reasons. Reason #1: You are a Subscriber but Not Signed In The only reason this should happen is if you are using a different device than the one you signed up with. You…